Sponsor Pipeline

Integro Theranostics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07276789 Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative… Non Small Cell Lung Cancer (NSCLC) Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Integro Theranostics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free